share_log

康哲藥業：截至二零二三年十二月三十一日止月份之股份發行人的證券變動月報表

CMS: Monthly Return of Equity Issuer on Movements in Securities for the month ended 31 December 2023

香港交易所 ·  Jan 2 03:58
Summary by Moomoo AI
康哲藥業控股有限公司於2024年1月2日向香港交易及結算所有限公司提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的法定/註冊股本結存維持在20,000,000,000股，每股面值0.005美元，總額100,000,000美元，本月無增減變動。已發行股份的變動詳情部分，包括股份期權、承諾發行權證、可換股票據及其他協議或安排等，均顯示為不適用，意味著在報告期內沒有相關活動。公司秘書吳三燕確認，所有證券發行均已獲得董事會批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
康哲藥業控股有限公司於2024年1月2日向香港交易及結算所有限公司提交了截至2023年12月31日的證券變動月報表。報告顯示，公司的法定/註冊股本結存維持在20,000,000,000股，每股面值0.005美元，總額100,000,000美元，本月無增減變動。已發行股份的變動詳情部分，包括股份期權、承諾發行權證、可換股票據及其他協議或安排等，均顯示為不適用，意味著在報告期內沒有相關活動。公司秘書吳三燕確認，所有證券發行均已獲得董事會批准，並符合香港聯合交易所有限公司證券上市規則的相關要求。
Congee Pharmaceutical Holdings Limited filed with Hong Kong Trading and Settlement Limited on 2 January 2024 its Monthly Securities Change Report for the year ended 31 December 2023. THE REPORT SHOWS THAT THE COMPANY'S STATUTORY/REGISTERED SHARE CAPITAL WAS MAINTAINED AT 20,000,000,000 SHARES WITH A FACE VALUE OF $0.005 PER SHARE FOR A TOTAL OF $100,000,000, WITH NO INCREASE OR DECREASE THIS MONTH. The movement details of the issued shares, including stock options, undertaking to issue warrants, convertible notes, and other agreements or arrangements, are shown as not applicable, meaning that there is no relevant activity during the reporting period. Company Secretary Wu Sanyan confirmed that all securities issues have been approved by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Congee Pharmaceutical Holdings Limited filed with Hong Kong Trading and Settlement Limited on 2 January 2024 its Monthly Securities Change Report for the year ended 31 December 2023. THE REPORT SHOWS THAT THE COMPANY'S STATUTORY/REGISTERED SHARE CAPITAL WAS MAINTAINED AT 20,000,000,000 SHARES WITH A FACE VALUE OF $0.005 PER SHARE FOR A TOTAL OF $100,000,000, WITH NO INCREASE OR DECREASE THIS MONTH. The movement details of the issued shares, including stock options, undertaking to issue warrants, convertible notes, and other agreements or arrangements, are shown as not applicable, meaning that there is no relevant activity during the reporting period. Company Secretary Wu Sanyan confirmed that all securities issues have been approved by the Board of Directors and comply with the relevant requirements of the Securities Listing Rules of the Hong Kong Stock Exchange Limited.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1     View Translation

Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more